Terns Pharmaceuticals, Inc.
TERN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $440 | $462 | $367 | $179 |
| - Cash | $161 | $80 | $143 | $48 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $280 | $383 | $225 | $131 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | – | – | 100% |
| EBITDA | -$101 | -$102 | -$61 | -$49 |
| % Margin | – | – | – | -4,934.8% |
| Net Income | -$89 | -$90 | -$60 | -$50 |
| % Margin | – | – | – | -5,015.8% |
| EPS Diluted | -1.12 | -1.27 | -1.67 | -1.98 |
| % Growth | 11.8% | 24% | 15.7% | – |
| Operating Cash Flow | -$70 | -$67 | -$49 | -$42 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$70 | -$67 | -$49 | -$42 |